Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells
- PMID: 20156581
- DOI: 10.1016/j.biocel.2010.02.005
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells
Abstract
Cell proliferation only proceeds when metabolism is capable of providing a budget of metabolic intermediates that is adequate to ensure both energy regeneration and the synthesis of cell building blocks in sufficient amounts. In tumor cells, the glycolytic pyruvate kinase isoenzyme M2 (PKM2, M2-PK) determines whether glucose is converted to lactate for regeneration of energy (active tetrameric form, Warburg effect) or used for the synthesis of cell building blocks (nearly inactive dimeric form). This review discusses the regulation mechanisms of pyruvate kinase M2 expression by different transcription factors as well as the regulation of pyruvate kinase M2 activity by direct interaction with certain oncoproteins, tyrosine and serine phosphorylation, binding of phosphotyrosine peptides, association with other glycolytic and non glycolytic enzymes, the promyelocytic leukemia tumor suppressor protein, as well as metabolic intermediates. An intervention in the regulation mechanisms of the expression, activity and tetramer to dimer ratio of pyruvate kinase M2 has severe consequences for metabolism as well as proliferation and tumorigenic capacity of the cells which makes this enzyme a promising target for potential therapeutic approaches. The quantification of the dimeric form of pyruvate kinase M2 (Tumor M2-PK) in plasma and stool allows early detection of tumors and therapy control. Several different mechanisms may induce a translocation of pyruvate kinase M2 into the nucleus. The role of pyruvate kinase M2 in the nucleus is complex as witnessed by evidence of its effect both as pro-proliferative as well as pro-apoptotic stimuli.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.Crit Rev Oncog. 1992;3(1-2):91-115. Crit Rev Oncog. 1992. PMID: 1532331 Review.
-
Pyruvate kinase type M2: a crossroad in the tumor metabolome.Br J Nutr. 2002 Jan;87 Suppl 1:S23-9. Br J Nutr. 2002. PMID: 11895152 Review.
-
The tumor metabolome.Anticancer Res. 2003 Mar-Apr;23(2A):1149-54. Anticancer Res. 2003. PMID: 12820363
-
Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.Exp Cell Res. 2009 Oct 1;315(16):2765-74. doi: 10.1016/j.yexcr.2009.06.024. Epub 2009 Jun 27. Exp Cell Res. 2009. PMID: 19563799
-
Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.Ernst Schering Found Symp Proc. 2007;(4):99-124. doi: 10.1007/2789_2008_091. Ernst Schering Found Symp Proc. 2007. PMID: 18811055 Review.
Cited by
-
Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.Neoplasia. 2013 Jun;15(6):620-30. doi: 10.1593/neo.13432. Neoplasia. 2013. PMID: 23730210 Free PMC article.
-
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness.Biomark Res. 2022 Aug 29;10(1):66. doi: 10.1186/s40364-022-00412-1. Biomark Res. 2022. PMID: 36038935 Free PMC article. Review.
-
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.World J Gastroenterol. 2012 Aug 14;18(30):4004-11. doi: 10.3748/wjg.v18.i30.4004. World J Gastroenterol. 2012. PMID: 22912551 Free PMC article.
-
Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.Yonsei Med J. 2016 Nov;57(6):1312-23. doi: 10.3349/ymj.2016.57.6.1312. Yonsei Med J. 2016. PMID: 27593857 Free PMC article.
-
Genetic variation of kinases and activation of nucleotide analog reverse transcriptase inhibitor tenofovir.Pharmacogenomics. 2019 Jan;20(2):105-111. doi: 10.2217/pgs-2018-0140. Epub 2019 Jan 10. Pharmacogenomics. 2019. PMID: 30628547 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous